Literature DB >> 22675153

Recurrent retroperitoneal liposarcoma in a patient with neurofibromatosis type I.

Carrie K Gomez1, Gerald Rosen, Robin Mitnick, Ali Chaudhri.   

Abstract

INTRODUCTION: Liposarcoma complicating neurofibromatosis is very rare. Only a few cases have been described until now. We present a case of recurrent dedifferentiated retroperitoneal liposarcoma in a patient with neurofibromatosis type I (NF-1). CASE
PRESENTATION: A 47-year-old Caucasian woman with NF-1 presented to the hospital initially complaining of left lumbar pain irradiating to the anterior thigh and knee. Physical examination showed atrophy of the lower extremities bilaterally and decreased motor strength on the left lower extremity. Radiological studies demonstrated an enhancing lesion in the left paraspinal region, suggesting malignancy. The patient underwent local resection of tumour with safety margins. Pathological examination was consistent with dedifferentiated liposarcoma (DDLS) with positivity for MDM2 and CDK4 markers. No evidence of metastasis was noted on the radiological studies. The final diagnosis was DDLS, high-grade (G3), pT2bN0M0, stage III. After 6 weeks post-tumour resection, the patient experienced recurrence of malignancy. Chemotherapy with cisplatin and doxorubicin was initiated in the patient.
CONCLUSIONS: Liposarcoma in the context of neurofibromatosis is very rare. To the best of our knowledge, only six cases have been reported until now in the literature. We are presenting this case to underline the possibility of recurrence in the case of retroperitoneal DDLSs despite local tumour resection. Also, although the role of chemotherapy is controversial we decided to start treatment with cisplatin and doxorubicin given the success of chemotherapy in similar case presentations.

Entities:  

Mesh:

Year:  2012        PMID: 22675153      PMCID: PMC4543264          DOI: 10.1136/bcr-2012-006310

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Omental liposarcoma; a rare complication in neurofibromatosis type 1.

Authors:  A Imai; K Onogi; Y Sugiyama
Journal:  J Obstet Gynaecol       Date:  2006-05       Impact factor: 1.246

2.  Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.

Authors:  J E DeClue; S Heffelfinger; G Benvenuto; B Ling; S Li; W Rui; W C Vass; D Viskochil; N Ratner
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 3.  Malignancy in neurofibromatosis type 1.

Authors:  B R Korf
Journal:  Oncologist       Date:  2000

4.  Liposarcoma of the forearm in a man with type 1 neurofibromatosis: a case report.

Authors:  Markus Dietmar Schofer; Mohammed Yousef Abu-Safieh; Jürgen Paletta; Susanne Fuchs-Winkelmann; Bilal Farouk El-Zayat
Journal:  J Med Case Rep       Date:  2009-04-29

5.  Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.

Authors:  Samuel Singer; Cristina R Antonescu; Elyn Riedel; Murray F Brennan
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

6.  The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution.

Authors:  Chiara Mussi; Paola Collini; Rosalba Miceli; Marta Barisella; Luigi Mariani; Marco Fiore; Paolo G Casali; Alessandro Gronchi
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

7.  Liposarcoma complicating neurofibromatosis. Report of two cases.

Authors:  N D Baker; F K Tchang; A Greenspan
Journal:  Bull Hosp Jt Dis Orthop Inst       Date:  1982

8.  Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathways.

Authors:  Ralf J Rieker; Juergen Weitz; Burkhard Lehner; Gerlinde Egerer; Andrea Mueller; Bernd Kasper; Peter Schirmacher; Stefan Joos; Gunhild Mechtersheimer
Journal:  Virchows Arch       Date:  2009-12-29       Impact factor: 4.064

9.  [A case of retroperitoneal dedifferentiated liposarcoma successfully treated with IFM and CDDP].

Authors:  Miki Yokoi; Kenzo Hosokawa; Hiroshi Funaki; Shinichiro Yoshitani; Shinichi Kinami; Kazuhiko Omote; Nobuhiko Ueda; Yasuharu Nakano; Takeo Kosaka; Hiroshi Minato
Journal:  Gan To Kagaku Ryoho       Date:  2009-11

Review 10.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

View more
  3 in total

Review 1.  Coincident liposarcoma, carcinoid and gastrointestinal stromal tumor complicating type 1 neurofibromatosis: Case report and literature review.

Authors:  Aaron W James; Le Chang; Scott Genshaft; Sarah M Dry
Journal:  J Orthop       Date:  2014-11-26

Review 2.  Surgical management of spinal liposarcoma: a case series of 7 patients and literature review.

Authors:  Chenglong Zhao; Zhitao Han; Hui Xiao; Cheng Yang; Yongfei Zhao; Tianqi Fan; Zhengwang Sun; Tielong Liu; Jianru Xiao
Journal:  Eur Spine J       Date:  2016-01-18       Impact factor: 3.134

3.  Synchronous recurrence of concurrent colon adenocarcinoma and dedifferentiated liposarcoma.

Authors:  Eric E Jung; F Scott Heinemann; Colt A Egelston; Jennifer Wang; Raphael E Pollock; Peter P Lee; William W Tseng
Journal:  BMJ Case Rep       Date:  2019-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.